6505--Nuclear Medicine Radiopharmaceuticals (VA-26-00043023) Request for Information
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Western NY VAMC in Buffalo, NY, is conducting a Sources Sought / Request for Information (RFI) to identify qualified vendors capable of providing Nuclear Medicine Radiopharmaceuticals. This is for market research purposes only; it is not a solicitation, and no contract will be awarded from this announcement. The VA intends to issue a solicitation at a later date for a three-year firm fixed-price contract. Responses are due by March 13, 2026, at 3 PM Eastern Time.
Scope of Work
The VA requires a licensed vendor to supply a comprehensive list of radiopharmaceuticals for its Nuclear Medicine Department for patient care. Key requirements include:
- Licensing: Must hold current US NRC or agreement state radioactive materials license, an FDA license to produce and distribute radiopharmaceuticals for human administration, and be licensed by the State of New York.
- Delivery: Capability to deliver within two hours to the VA Western NY Healthcare System at Buffalo, with up to two deliveries per day included, and emergency deliveries within two hours.
- Quality Control: Adherence to Federal, State, Joint Commission (JC), and United States Pharmacopeia (USP) standards, including pH testing, percent tag, alumina, and 99Mo breakthrough.
- Packaging & Labeling: Compliance with all Federal and State regulations (FDA, DOT, DOE, USNRC, ICC), with clear radioactive labeling and adequate shielding.
- Disposal: Contractor must pick up used and unused radiopharmaceuticals for proper disposal at no cost.
- Personnel: Services must be provided by Nuclear Pharmacists or Licensed Technologists under supervision.
Contract & Timeline
- Type: Sources Sought / Request for Information (future intent for Firm Fixed Price contract)
- Period of Performance (Intended): Three years, from July 1, 2026, through June 30, 2029.
- Set-Aside: This requirement will be Set-aside for Small Business.
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing).
- Response Due: March 13, 2026, 3 PM ET.
- Published: March 7, 2026.
Submission & Evaluation
Interested contractors are requested to submit a statement of capabilities addressing how they can meet the Government's requirements. The submission should include:
- Company Name, Address, DUNS Number, POC Name, Phone, Email, and Website.
- Business type (Small, VOSB/SDVOSB, etc.).
- GSA Contract and # (if applicable).
- Statement on whether brand name or equal product is Domestic or Non-Domestic.
- Evidence of ability to make 2-hour deliveries (e.g., point of shipment location via MapQuest).
Responses are for market research only to assist the VA in determining sources. Responses to this RFI are not considered adequate responses to any future solicitation.
Additional Notes
Prospective contractors must be registered in SAM and complete electronic annual representations and certifications. Subcontracting is not authorized, and multiple awards will not be made. The contractor must comply with HIPAA, HHS/OIG exclusion lists, and CPARS reporting requirements.